Baxter International Inc. (BAX) is a Healthcare stock trading at $19.90 (as of 2026-06-18), with a market capitalization of $9.58B and a trailing P/E of -9.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Baxter International Inc., through subsidiaries, provides healthcare products and services worldwide across dialysis therapies, intravenous therapies and related delivery devices, oncology and inhaled anesthesia products, parenteral nutrition, and certain surgical products and biological devices. It also offers connected care and patient monitoring solutions, including devices, software, communications, and integration technologies, for clinical care settings.